Today: 7 February 2026
Subscribe
Browse Category

LSE:BAB News 2 January 2026 - 28 January 2026

Babcock share price edges up after new buyback filing, near 52-week high

Babcock share price edges up after new buyback filing, near 52-week high

Babcock shares rose about 1% to 1,509p in early London trading after the company disclosed it repurchased 15,093 shares on Jan. 27. The stock traded between 1,500.66p and 1,518p, just below its 52-week high. Total buybacks since July 24 reached 7.93 million shares, costing £88.47 million. Traders are watching for further contract announcements and procurement signals.
28 January 2026
·
UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

The FTSE 100 fell 0.13% to 10,136.43 on Friday, reversing early gains as strong UK retail sales and a jump in business activity fueled speculation the Bank of England may delay rate cuts. Retail sales rose 0.4% in December, beating forecasts, while the UK Composite PMI hit 53.9, its highest since April 2024. Babcock shares slipped 1.2% after its CEO announced plans to retire. C&C Group dropped 9.6% on a profit warning.
23 January 2026
····
FTSE 100 hits 10,000 after best year since 2009

FTSE 100 hits 10,000 after best year since 2009

NEW YORK, January 2, 2026, 03:53 ET Britain’s FTSE 100 hit the 10,000 level for the first time on Friday, capping a surge that left the index up nearly 22% in 2025, its strongest annual showing since 2009. The benchmark beat both the pan-European STOXX 600 and the U.S. S&P 500 last year, while the more domestically focused FTSE 250 rose about 9%. Miners such as Fresnillo, defence contractors including Babcock and Rolls-Royce and banks led by Lloyds powered gains in a market with limited exposure to artificial intelligence (AI) stocks. Reuters The milestone follows a year in which the
2 January 2026
·····

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop